Physician profile
Ursula Steadman
NPI 1821095225
$853.26
in general payments reported to CMS, 2019-2025
18 companies · $23.26 in 2025
The $23.26 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $218 · 2020: $141 · 2021: $233 · 2022: $110 · 2023: $127 · 2025: $23.26.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $150.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $145.87 | 2021-2023 | Orilissa, Lo Loestrin Fe |
| Therapeuticsmd, INC. | $121.84 | 2019-2022 | |
| Duchesnay USA Incorporated | $109.54 | 2019-2020 | |
| Pfizer INC. | $70.94 | 2020-2023 | |
| Millicent US INC | $60.05 | 2019-2025 | Femlyv |
| Bayer Healthcare Pharmaceuticals INC. | $59.19 | 2019-2023 | |
| Exeltis, USA INC. | $41.82 | 2021-2023 | Slynd |
| Myovant Sciences INC. | $38.58 | 2021-2022 | |
| Amag Pharmaceuticals, INC. | $34.35 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $24.92 | 2023 | Myfembree |
| Evofem Biosciences, INC. | $23.38 | 2021 | |
| Mayne Pharma Commercial LLC | $23.33 | 2021 | |
| Merck Sharp & Dohme LLC | $19.03 | 2020 | |
| Coopersurgical, INC. | $17.78 | 2022 | |
| Bausch Health US, LLC | $16.25 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $16.01 | 2023 | Cologuard Collection Kit |
| Minerva Surgical, INC | $15.65 | 2019 | |
| Mylan Pharmaceuticals INC. | $14.73 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ursula Steadman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.